Trial Profile
Pivotal phase III trial of ciprofloxacin 0.3% otic foam (FoamOtic Externa) in patients with acute otitis externa.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Otitis externa
- Focus Registrational; Therapeutic Use
- Sponsors Eledon Pharmaceuticals; Otic Pharma
- 10 May 2017 According to Tokai Pharmaceuticals Media Release, Tokai Pharmaceuticals has merged with Otic Pharma and subsequently changed its name to Novus Therapeutics.
- 22 Jan 2015 New trial record